Structural transformation in vesicles upon hydrolysis of phosphatidylethanolamine and phosphatidylcholine with phospholipase C by Fong, W-K et al.
This is a repository copy of Structural transformation in vesicles upon hydrolysis of 
phosphatidylethanolamine and phosphatidylcholine with phospholipase C.




Fong, W-K, Sanchez-Ferrer, A, Rappolt, M orcid.org/0000-0001-9942-3035 et al. (2 more 
authors) (2019) Structural transformation in vesicles upon hydrolysis of 
phosphatidylethanolamine and phosphatidylcholine with phospholipase C. Langmuir, 35 
(46). acs.langmuir.9b02288. pp. 14949-14958. ISSN 0743-7463 
https://doi.org/10.1021/acs.langmuir.9b02288
© 2019 American Chemical Society. This is an author produced version of a paper 




Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
1 
 
Structural transformation in vesicles upon hydrolysis of 
phosphatidylethanolamine and phosphatidylcholine with 
phospholipase C 
Wye-Khay Fonga,b,c*1, Antoni Sánchez-Ferrera, Michael Rappoltd, Ben J. Boydb and Raffaele 
Mezzengaa* 
aETH Zürich, Department of Health Sciences & Technology, 8092 Zürich, Switzerland; bDrug Delivery, 
Disposition and Dynamics, and ARC Centre of Excellence in Convergent Bio-Nano Science and 
Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, 381 
Royal Parade, Parkville, VIC 3052, Australia. cAdolphe Merkle Institute, University of Fribourg, 
Chemin des Verdiers 4, 1700 Fribourg, Switzerland. dSchool of Food Science and Nutrition, University 
of Leeds, LS2 9JT, United Kingdom 
*Raffaele.mezzenga@hest.ethz.ch & khay.fong@newcastle.edu.au  
Abstract 
This study provides insight into dynamic nanostructural changes in phospholipid systems during 
hydrolysis with phospholipase C, the fate of the hydrolysis products and the kinetics of lipolysis. The 
effect of lipid restructuring of the vesicle was investigated using small-ang e X-ray scattering and 
cryogenic scanning electron microscopy. The rate and extent of phospholipid hydrolysis was quantified 
using NMR. Hydrolysis of two phospholipids, phosphatidylethanolamine and phosphatidylcholine, 
results in the cleavage of the molecular headgroup, causing two strikingly different changes in lipid 
self-assembly. The diacylglycerol product of phosphatidylcholine escapes the lipid bilayer, whereas the 
diacylglycerol product adopts a different configuration within the lipid bilayer of the 
phosphatidylethanolamine vesicles. These results are then discussed concerning the change of lipid 
configuration upon the lipid membrane and its potential implications in vivo, which is of significant 
importance for the detailed understanding of the fate of lipidic particles and the rational design of 
enzyme-responsive lipid-based drug delivery systems. 
Abbreviations 
PLC – phospholipase C; sPC – soy phosphatidylcholine; ePE – egg phosphatidylethanolamine;  




In the search for better medical treatments, lipid-based drug delivery system  have been used to 
improve therapeutic outcomes. However, the in vivo fate of these materials is still unclear. Lipid 
hydrolysis is an important process for the absorption of nutrients and cellular signalling. There remains 
considerable uncertainty about basic enzyme function and consequently, the mechanism of lipolysis as 
well as the malfunction of lipases in disease states such as obesity, diabetes, and atherosclerosis. 
Additionally, the solubility of some lipid soluble drugs and nutrients are int insically linked to the fate 
of the drug delivery formulation and drug distribution is dictated by the typ of colloidal phases 
generated during digestion.1-3 
Nanostructured lipid particles can be designed, built and applied as vehicles for stimuli responsive 
drug delivery. By switching between the different self-assembled mesophases, the inherentrelease rates 
of each nanostructure can be utilised.4-7 Additionally, the formation of complex inverse nanostructures 
is implicated in the promotion of membrane fusion. Thus, understanding the way that lipidic particles 
are processed in the body is key to their therapeutic application. The action of lipases u on lipid self-
assembly during intestinal digestion are important in directing the absorption of fat-s luble drugs and 
nutrients. Lipolysis has been shown to modify the self-assembly of a range of different commonly 
encountered lipid colloids, where the extent and direction of the reaction is also contingent o  the 
presence of bile salts and pH.8 For instance, emulsions formed by medium chain triglycerides transition 
to vesicles upon digestion;9 monoolein based cubosomes transition from inverse cubic through a variety 
of inverse nanostructures to dispersed oil droplets upon hydrolysis;10 milk emulsions (triglycerides) 
transition to a variety of differently ordered nanostructures.8, 11 The selective lipolysis of lipids from the 
interface of lipidic particles can also direct the phase transitions,12-13 where the products of hydrolysis 
align themselves within the lipid bilayer according to their physicochemical properties.14 
Towards the development of enzyme-responsive lipid-based nanomaterials as drug delivery 
systems, this study seeks to understand the changes in nanostructure of phosphatidylcholine (PC) a d
phosphatidylethanolamine (PE) based particles under the action of phospholipase C (PLC); an 
interfacialy active enzyme that was until recently viewed only as an instrument of lipidic degradation. 
The role of PLC in physiology is well understood,15-16 however, it is the discovery of role of PLC in 
disease states17-18 that has renewed interest in the in vivo function of phospholipase C and painted them 
as a target for drug delivery. 
Both PE and PC are extensively used in different ratios in the formulation of liposomal drug 
delivery products, however the molecular mechanisms of their respective roles in th  final delivery to 
the site of action is not completely understood. The site of PE and PC cleavage by thr e types of 
phospholipases are shown schematically in Fig. 1. Thus, in this study, lipolysis as a mediator for 
triggered drug release and vesicle fusion was investigated. As the differnt phospholipids play different 
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roles both in lipid homeostasis, as well as drug delivery, it is important to study the dynamic behaviour 
of these formulations in order to understand both the contradictory events of unexpected drug release 
and the enhancement of drug release by this mechanism.  
 
Fig. 1 – Representative molecular structures of the major components of soy phosphatidylcholine (sPC) and egg 
phosphatidylethanolamine (ePE) utilised in this study. The coloured bars represent the location of molecular 
cleavage catalysed by different phospholipases (PL): PLA2 (red), PLC (blue) and PLD (green). This study focuses 
on the action of phospholipase C (PLC). 
Experimental 
Materials 
Egg phosphatidylethanolamine (ePE) and soy phosphatidylcholine (sPC) Lipoid S100 were 
obtained from Lipoid AG (Switzerland); compositions are detailed in Table 1. Phospholipase C from 
Bacillus cereus, dipotassium hydrogen phosphate and calcium chloride were purchased from Sigma 
Aldrich. Dilinolein (dilinoleoylglycerol) was purchased from Nu-Chek Prep (MN, USA). Sodium 
chloride and sodium dihydrogen phosphate were purchased from Merck. Pluronic F127, a hydrophilic 
tri-block copolymer (PEG-PPG-PEG), was obtained from BASF SE (Germany). 
Table 1 – Fatty acid composition of the phospholipid tails used in this study, as provided by Lipoid AG. Average 
number of unsaturations were determined via 1D 1H and 13C NMR. 
Fatty acid   ePE 
(%) 
sPC (%) 
Palmitic C16 30-35 12-17 
Stearic C18 10-15 2-5 
Oleic  C18:1 30-38 7-12 
Linoleic C18:2 12-18 59-70 
Linolenic C18:3 - 5-8 
Unsaturations/moleculea  1 4 
a Average number of unsaturations per phospholipid molecule evaluated from the chemical composition and 




Phospholipids were weighed into round bottom flasks and dissolved in a 
dichloromethane:methanol (2:1) mixture. Thin films of phospholipids were then formed by removing 
the solvent via rotary evaporation. For the dynamic studies, the lipid films were formed with either ePE 
or sPC only (5% w/v). For the equilibrium studies, the lipid films were formed by incorporating a model 
diacylglycerol, dilinolein, which is the major component from sPC hydrolysis, in defined molar ratios.
The lipids were then hydrated in phosphate buffered saline (PBS) (5 wt% lipid, 50 mM phosphate 
buffer, pH 7.4) or in PBS containing Pluronic F127 (0.5 wt% F127, 5 wt% lipid, 50 mM phosphate 
buffer, pH 7.4) to form vesicles. The coarse dispersions were further processed by ultrasonication (10 
min pulsed, 30% amplitude) in order to reduce and homogenise the particle size. 
Small angle X-ray scattering (SAXS) 
SAXS was used to investigate the aggregates formed in equilibrium mixtures. Experiments were 
performed using a Rigaku S-Max 3000 SAXS system (Japan) equipped with a copper-target micro 
focus X-ray tube MicroMax-002+ (45 kV, 0.88 mA). The Ni-filtered Cu Kg radiation (Cu Kg = 1.5418 
Å) was collimated by a three pinhole collimator (0.4, 0.3 and 0.8 mm in diameter), and the data were 
collected by a two dimensional argon-filled Triton-200 X-ray detector (Rigaku, Japan; 20 cm diameter, 
200 µm resolution). An effective scattering-vector range of 0.006 Å-1 < q < 0.4 Å-1 was investigated, 
where q is the scattering wave-vector defined as q = 4ヾ sinし/Cu Kg, with a scattering angle of 2し. For 
all measurements, the samples were filled into a 1.5 mm internal diameter quartz capillary and sealed 
with epoxy glue. Measurements were performed at 37 °C, where samples were equilibrated for 30 min 
prior to measurements. The scattered intensity was collected over 2.5 h. 
Time-resolved synchrotron SAXS: In vitro digestion experiments were conducted using a 
thermostated glass digestion vessel at 37 °C, fitted with tubing to enable flowthrough scattering analysis 
to be conducted in real time.19 To 7 mL of lipid dispersion in the glass vessel, 0.5 mL of a 1 mg·mL-1 
phospholipase C solution in PBS was added using a remotely driven syringe pump, while the digesting 
medium was pumped through a 1.5 mm quartz capillary flow cell at 10 mL·min-1 usi g a peristaltic 
pump. The quartz capillary was placed in the X-ray beam at the SAXS/WAXS beamlin  at the 
Australian Synchrotron.20 Scattering profiles were acquired for 5 s every 10 s at an energy of 10 keV 
using a Pilatus 1 M detector (Dectris, Switzerland; active area 169 × 179 mm2 with a pixel size of 172 
たm) with a sample-to-detector distance of 1.6 m providing a q-range of 0.01 < q < 0.6 Å–1, where q is 
the length of the scattering vector defined by q = 4ヾ sinし/そ, with そ being the wavelength and 2し the 
scattering angle. The scattering images were integrated into the one-dimensional scattering function 
I(q) using the in-house developed software package ScatterBrain. The q-range calibration was made 
using silver behenate as the standard. The liquid crystalline space groups and lattice param ters (欠) 
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were determined by the relative positions of the Bragg peaks in the scattering curves, which correspond 
to the reflections on planes defined by their (hkl) Miller indices.21 
As the quality of the diffraction data of these multi-component and multi-colloidal systems was 
limited by experimental constraints, both simple bilayer models (sPC samples), as well as classical 
Fourier synthesis (ePE samples), were utilised to estimate the bilayer thickness in the fluid lamellar 
phases.22-23 Briefly, after background subtraction, all diffraction peaks were fitted with Lorentzian 
distribution using Origin 2016, and finally, the resulting intensities, Ih, were Lorentz corrected in order 
to obtain the form factor values Fh (for details see reference 22 and therein). The electron bilayer profiles 
(EDP) were then determined by (Fig. SI-1):  ッび岫権岻 噺 デ 糠朕 ┻ 繋朕 ┻ cos 岫態訂朕佃鳥 岻朕 陳銚掴朕退怠                   (1) 
Where h is the Miller index, gh are the phases, Fh are the form factors, and d denotes the d-spacing 
of the lattice and z is the distance in real space. sPC bilayers were estimated by the ‘two-peak method’ 
detailed in reference,23 which utilises the experimental form factors, F1 and F2, and average material 
parameter values from literature to estimate the head group at the positions ±zH. For comparison, a 
modified Luzzati method 24 for determining bilayer dimensions was also considered, but the latter 
results are only discussed in the Supplementary Information together with the results of the ‘two-peak 
method’. 
The structural parameters of the HII phase formed by ePE and ePE/F127 were estimated from 
electron density maps calculated by standard Fourier synthesis according to reference 25. Si  only the 
first three orders were recorded throughout, i.e., the (10), (11) and (20) reflections, the deduced mean 
head-group position, RH (for definition, see Figure SI-2) is underestimated. Note, from such low 
resolution electron density maps the true electron density position RH* can only be estimated following 
the method of reference 25. The following equations were applied: 
RH* = 1.12 RH           (2) 
a = 2 RH* + dHH           (3) 
2 RW = 2 RH* - 11 Å          (4) 
Where a is the lattice parameter, RH is experimental head group radius, dHH is the shortest head to 
head group distances (for definitions see Figure SI-2), RW is the water core radius and 11 Å is a 
commonly applied estimation of the radial head group extension.25 
Nuclear Magnetic Resonance (NMR) 
To evaluate the composition of the products of phospholipid hydrolysis, 1D 1H and 13C NMR 
experiments, as well as DEPT and 2D 1H-1H (COSY) and 1H-13C (HETCOR) NMR experiments were 
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carried out on a Bruker Advance spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany), 
operating at 400 MHz (1H) and 100 MHz (13C), and using D2O or DMSO-d6 as solvents and as internal 
standards. Example NMR spectra are presented in the ESI (Fig. SI-2). 
The process of hydrolysis was quantified by 1H NMR by following the apparition and evolution of 
a peak (quintuplet) at  = 5.08 ppm, which corresponds to a single H in C2 from the glycerine moiety, 
upon hydrolysis of the phosphate ester between the phosphatidic acid and glycerol moiety. The 
integrated area was normalized taking into account the constant area corresponding t  the peak 
(multiplet) at  = 0.87 ppm of the two terminal CH3 groups in the fatty tails. Data were fitted to consider 
an increase in particle size over time (Table SI-2) as per equation (5), where H r f rs to the extent of 
reaction, t, time in minutes and ki the rate of hydrolysis. 茎岫建岻 噺 茎陳銚掴 デ 茎沈盤な 伐 結貸賃日痛匪態沈退怠         (5) 
Cryogenic scanning electron microscopy (cryoSEM) 
Approx. 6 µL of the lipid dispersions (5% w/v, 7 mL) undergoing PLC catalysed hydrolysis (0.5 
mL of a 1 mg·mL-1) were loaded into aluminium half shells and then frozen under high pressure (2100 
bar) with liquid nitrogen and within milliseconds using the Bal-Tec HPM100 (Leica) high-pressure 
freezing system. Rapid freezing prevents the formation of ice crystals which ot erwise would have 
affected the delicate nanostructure of the liquid-crystalline nanoparticles. Flash freezing the samples in 
real time also arrests the action of the enzymes whilst avoiding the use of enzyme inhibitors, which may 
alter the ultrastructure of the particles. Using a freeze-fracture system (BAF 060, Baltec) the samples 
were fractured with a diamond knife and coated with 6 nm of tungsten in the frozen state in order to 
prevent surface charging during imaging. A cryo-transfer device was then used to transport the frozen 
material to a SEM instrument (Zeiss Leo 1530). 
Results 
The hydrolysis of the vesicles formed by the two phospholipids resulted in vastly different dynamic 
phase behaviour driven by the reduction in headgroup size to form diglycerides. Specifically, the 
diacylglyceride products (DAG1 and DAG4 from ePE and sPC, respectively; numbers refer to th  
average number of unsaturations in the lipidic tail as shown in Table 1) can influence th  self-assembly 
of the lipids at the interface due to their specific amphiphilic nature. The dynamic transformation of 
structure was followed by synchrotron SAXS and cryoSEM, and changes in composition was f llowed 
by NMR. These results were then compared to equilibrium structural studies as determined by SAXS. 




The structural evolution caused by hydrolysis of dispersed ePE, both with a polymeric stabiliser 
(Pluronic F127) (ePE/F127) and without (ePE), were followed by time-resolved synchrotron SAXS 
(Fig. 2 and Fig. SI7). The phase transitions of ePE and ePE/F127 were very similar: Lg  Lg + HII  
HII  fluid isotropic  unstructured emulsion and/or aggregation. However, they differ in the timing 
of the phase transitions and colloidal stability. It is noted that in the absence of the enzyme, there was 
no change in the ePE dispersion over time, i.e., the fluid lamellar phase Lg was conserved over the entire 
observation period of half an hour (Fig. SI-4A). The phase transitions and timing of the PLC catalysed 
hydrolysis are as follows: 
ePE: Lg  Lg + HII (175 s)  HII (350 s)  2 × HII (405 s)  unstructured emulsion (636 s). Even 
with constant agitation, the flow of the sample became blocked due to aggregation of the lipid particles 
after 700 s. This is attributed to the loss of the charged moieties on the PE hadgroup that initially 
provide electrostatic stability of the dispersion, but its loss then contributes to the d minating fusogenic 
nature of DAGs.26 The second HII phase is minor compared to the main HII phase; the dual phases are 
highlighted in Fig. SI7. The presence of multiple HII phases may be an indication of particle aggregation 
preventing full access of the enzyme to its substrate. 
ePE/F127: Lg  Lg + micelles (147 s)  Lg + HII (386 s)  HII (828 s)  fluid isotropic (1610 s) 
 unstructured emulsion (1653 s). As the dispersion containing the non-ionic surfactant was more 
colloidally stable during hydrolysis, it was further investigated using cryoSEM (Fig. 3). The timing and 
evolution of images are: (1) 30 s unilamellar vesicles, (2) 315 s multilamellar onion-like vesicles, (3) 
611 s striations consistent with the inverse micellar rods of HII, as well as multilamellar vesicles, (4) 
1800 s fluid isotropic phase, and (5) 3610 s unstructured emulsion. 
Changes in the structural changes in bilayer and water spacings are shown in Fig. 2, right (for 
derivations see SI pages 1-3). Both the ePE and ePE/F127 formulations demonstrated almost identical 
changes over time, albeit at different times. As the ePE dispersion was hydrolysed, a slight increase in 
Lg bilayer thickness, dHH, and reduction of Lg water layer thickness, dW, was observed, attributed to both 
the incorporation of a finite amount of DAG1 into the hydrophobic tail region and the reduction of 
bound water to the hydrolysed headgroups. The transition to the HII phase was accompanied by the 
reduction of dHH by ~3.7 Å and an increase in free water, as has been observed with an increase i  





Fig. 2 – Left: time resolved SAXS intensity profiles showing the evolution of structure of egg 
phosphatidylethanolamine (ePE, top; panel A) and ePE dispersed in 0.5% Pluronic F127 (ePE/F127, bottom; panel 
B) during hydrolysis with PLC. Note: To avoid the obscuration of diffraction patterns with lower intensities, frames 
are plotted in inverse temporal order. Single SAXS intensity profiles highlighting key diffraction patterns during 
hydrolysis can be found in Fig. SI-4. Right: changes of structural parameters over time: the phospholipid 
headgroup-headgroup distance, dHH, and water lamellae thickness, dW, of the Lg phase, and the shortest 
headgroup-headgroup distance dHH and radius of the water channel, RW, of the HII phase are given (for definitions 




Fig. 3 – Representative cryoSEM images at selected time points showing the structure of structure of egg 
phosphatidylethanolamine dispersed in 0.5% F127 solution (ePE/F127) vesicles during PLC catalysed hydrolysis 
(scale bar = 500 nm). Additional representative SEM images can be found in the Fig. SI-5.  
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Structural changes resulting from PLC-catalysed hydrolysis of soy 
phosphatidylcholine (sPC) 
PLC catalysed hydrolysis of sPC vesicles resulted in a decrease in intensity of the lamellar peaks 
without any significant change in lattice parameter of the lamellae over the course of hydrolysis, 
corresponding to a slight increase in dHH coupled to a slight decrease in dW (Fig. 4, top). This is in 
agreement with a previous study, however, a phase transition was not observed as was hypothesised by 
the authors.27 We attribute the slight changes in the lamellar structure to the incorporation of a limited 
amount of DAG4 into the lipid bilayer. The separation of an oil phase was also observed, which was 
found to be reversible upon a large input of external energy; intense probe sonication was required for 
the insertion of DAG4 into the lipid bilayer and consequently the formation of the HII phase (Fig. SI-
6). The hydrolysis of sPC with phospholipases D (PLD) and phospholipases A2 (PLA2) also progressed 
without a change in nanostructure (Fig. SI-7); for brevity, this is further discussed in the SI. 
The sPC/F127 dispersion was initially constituted of a mixture of vesicles and micelles. PLC 
catalysed hydrolysis resulted in a decrease in intensity of the lamellar peaks of the vesicles, 
accompanied by a massive growth in intensity at low q-values, an indication of the sequ stration of the 
DAG4 into micellar structures that grow over time (Fig. 4, bottom). Interestingly, opposite trends in 
structural spacings were observed: a decrease in dHH accompanied by an increase in dW, which is 
attributed to the movement of the hydrophobic products of digestion into the growing micelles leading 
to an overall increase in membrane fluidity. The hydrolysis of sPC/F127 was also followed using 
cryoSEM (Fig. 5). At each time point, phase behaviour analogous to time-resolved SAXS was observed: 
(1) 10 s unilamellar vesicles; (2) 364 s small unilamellar vesicles and the phase separation and 
coalescence; (3) 680 s multilamellar vesicles, phase separation and coalescence; (4) 1935 s coalescence 
and the growth of oil droplets; and (5) 3630 s coalescence and the growth of oil dr plets. Oil droplets 
were differentiated from vesicles by the lack the lamellar structure. The images at 680, 1935 and 3630 






Fig. 4 –Left: time resolved SAXS intensity profiles showing the evolution of structure of soy phosphatidylcholine 
vesicles (sPC, top; panel A) and sPC dispersed in 0.5% F127 solution (sPC/F127, bottom; panel B) during 
hydrolysis with phospholipase. Right: membrane and water layer thicknesses over time. The phospholipid 
headgroup-headgroup distance, dHH, and water lamellae thickness, dW, of the Lg phases were determined in both 




Fig. 5 – Representative cryoSEM images at selected time points showing the structure of soy phosphatidylcholine 
dispersed in 0.5% F127 solution (sPC/F127) vesicles during PLC catalysed hydrolysis (scale bar = 500 nm). At 
time points 680, 1935 and 3630 s, images of the same sample position are shown using both the in-lens and 
backscattered electron detectors in order to show the details of the surfaces in the depth of the image. A 
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multilamellar vesicle is indicated with a red arrow. Additional representative SEM images can be found in the Fig. 
SI-8. 
Hydrolysis of ePE and sPC vesicles: quantification of hydrolysis products by NMR 
Hydrolysis of the ePE vesicles occurs under two conditions and at two distinct ra es (Fig. 6 and 
Table 2). The hydrolysis (H1 = 49%) occurs at a faster rate of k1 = 0.38 min-1 and with a proportion of 
the material (H2 = 51%) hydrolysed at a rate about 50 times slower (k2 = 0.0068 min-1). Most of the 
hydrolysis occurred at a faster rate, with a smaller proportion of the material hydrolysed at a rate 50-
fold slower. This second slower rate is attributed to the diffusion of lipids from within the vesicle to the 
lipid-water interface,28-29 as this must occur before the lipids can be hydrolysed by PLC. A lag time that 
has previously been observed in PLC catalysed hydrolysis of lipids was not observed.30 
The ePE particles in the absence of a stabiliser undergo hydrolysis at a slower rate and to a lower 
extent (56% of hydrolysis) by approximately 15%. The hydrolysis reaction occurs at a faster rate and 
greater extent (k1 = 0.58 min-1 and H1 = 74%; k2 = 0.0017 min-1 and H2 = 26%; 71% of hydrolysis), in 
the presence of the stabiliser. This reflects the stability of the ePE/F127 dispersions, which did not 
aggregate upon hydrolysis.  
The increased rate of hydrolysis of the ePE/F127 formulation did not coincide with an increased 
rate of structural change when compared to the bare particles. Instead, nanostructural changes were 
observed to occur more slowly. The presence of the stabiliser prevented the aggregation of the 
nanostructured lipidic particles and could be participating in the lipid reorganisation thereby stabilising 
the system against a phase transition. The stabilised particles follow the same ph se transitions as the 
bare particles, demonstrating that the steric hindrance provided by the surfactant does ot alter the way 
the enzymes approach and hydrolyse the ePE at the interface. 
Hydrolysis of sPC/F127 occurs in two environments and at two distinct rates (k1 = 0.47 min-1 and 
H1 = 35%; k2 = 0.0027 min-1 and H2 = 65%, Fig. 6 and Table 2), in the same fashion as the ePE 
formulations and with a hydrolysis yield of 38%. Note that the rate and extent of hydrolysis of the sPC 
formulation without stabiliser could not be determined due to phase separation and consequent 
inhomogeneity of the sample. The hydrolysis of sPC occurred mostly at the slower rate, which relates 
to the speed of translocation of the PC to the interface.31-32 The hydrolysis also did not proceed to the 
same extent as in the ePE formulations, which is attributed to the system being saturated with product. 
In the ePE systems, the DAG1 product was ‘removed’ from the bulk by rearranging within the lipidic 






Fig. 6 – The extent of A. egg phosphatidylethanolamine hydrolysis with (ePE/F127) & without (ePE) stabiliser 
(Pluronic F127), and B. soy phosphatidylcholine with stabiliser (sPC/F127) by PLC as determined by 1H NMR 
analysis. The solid line represents the fit of the data with equation (5) in the SI. 
 
Table 2: The reaction rate (k) and extent (H) of hydrolysis of ePE and sPC formulations with PLC as determined 
by 1H NMR, where H1 and k1 are attributed to hydrolysis occurring at the lipid-water interface, H2 and k2 to the 
diffusion of the phospholipid to the lipid-water interface, and Hmax refers to the maximum amount of hydrolysis that 
occurs. 
Formulation H1 k1 (min-1) H2 k2 (min-1) Hmax 
ePE 49% 0.38 51% 0.0068 56% 
ePE/F127 74% 0.58 26% 0.0017 71% 
sPC/F127 35% 0.47 65% 0.0027 38% 
Equilibrium phase behaviour of phospholipid dispersions 
The equilibrium phase behaviour of ePE/F127 and sPC/F127 was studied to understand the 
potential of the systems to form non-equilibrium phases. At high temperatures, ePE/F127 intrinsically 
formed inverse phases – the inverse hexagonal phase, HII, and the bicontinuous cubic phase with the 
space group Im3m (Fig. 7A and 7B) as previously observed.33 On the other hand, sPC/F127 did not 
form inverse phases with an increase in temperature (Fig. 7C).  
It has been previously shown that the incorporation of DAG into PC bilayers promotes the 
formation of inverse phases,27, 34-35 which was not observed in the time-resolved SAXS studies. The 
deliberate incorporation of dilinolein, a model DAG which represents the majority product from the 
hydrolysis of sPC, into sPC vesicles resulted in the formation of inverse phases – the bicontinuous cubic 
phase with the space group Pn3m at 16 mol%, and then HII phase at 29 mol% (Fig. 7D). The presence 
of DAG in the phospholipid bilayer favours negative bilayer curvature as their relatively small 









































headgroup allows them to position themselves deeper into the hydrophobic interior of the bilayer, where 
they modify the spacing between PC molecules that results in increased molcular ordering of the 
surrounding PC molecules and consequent reduction in the lateral diffusion of molecules.36-37 Although 
the hydrolysis of the sPC progressed beyond 65 mol% in the dynamic studies, phase separation w s 
observed, but not a phase transition, suggesting that it is more energetically favourable for DAG4 to 







Fig. 7 – Equilibrium phase behaviour of dispersions of ePE/F127 and sPC/F127 without and with DAG. A. 
Temperature dependence of the phase behaviour of ePE/F127 without DAG. In coexistence regimes the asterisk 
(*) indicates most dominant mesophase and the second most intense phase is marked with a hash (#). B. Selected 
SAXS patterns that highlight the phase changes. C. Temperature dependence of the phase behaviour of sPC/F127 
without DAG. D. Selected SAXS patterns of sPC/F127 containing increasing amounts of dilinolein. The reflections 
of the different liquid-crystalline phases are annotated in panel B and D for the Lg phase (black), for the bicontinuous 





In this study, the kinetics of PLC-catalysed lipid hydrolysis of ePE and sPC was observed, with a 
focus upon the dynamic nanostructures formed by the reorganisation of the hydrolysis products within 
the lipid bilayer. The presence of a non-ionic block copolymer surfactant, Pluronic F127, used to 
stabilise the lipid-water interface of the vesicle, mildly accelerated th  rate and increased the extent of 
hydrolysis but did not prevent access of the enzyme to its substrate. The resulting phase behaviour 
differed greatly. ePE formed inverse phases, where the presence of the surfactant maintins the liquid-
crystalline mesophases formed for a longer period. In comparison, sPC vesicles did not change in 
structure upon exposure to PLC, but the resulting DAG phase separates. Further, the presence of the 
stabiliser in the system results in the creation of micellar structures that grow over time due to the phase 
separation of the DAG and its subsequent incorporation into the micelles. 
When both the ePE and sPC are hydrolysed, the removal of the phosphorylethanolamine or 
phosphorylcholine from the headgroup reduces the polarity of the amphiphile, thus removing the major 
barrier to trans-bilayer movement and allowing for the rapid equilibration of DAG within (and out of) 
the system.38-40 What is demonstrated in this study is how bilayers comprising of the two different typ s 
of phospholipids respond to the stress induced by the production of DAG. Alone, DAG is a viscous 
liquid that is uncharged, extremely hydrophobic, and therefore immiscible with and highly buoyant in 
water. DAGs are normally minor lipid constituents in cells, but they play key roles in several biological 
processes, including as a second messenger in cellular signal transduction.41 The interaction of DAGs 
with key phospholipids in lipid membranes potentially determines their biological fate, and will be 
discussed in terms of lipid incompatibility and its effect on the membrane curvature. 
It was observed that DAG deliberately incorporated into sPC lipidic bilayers in the equilibrium 
studies behave differently to dynamically produced DAG4 via PLC hydrolysis. The phase separation 
of the DAG4 is a consequence of increased hydrophobicity upon removal of the headgroup, particularly 
given that the acyl chains are >10 carbons in length (Table 1).42 It was initially thought that the 
distribution of DAG during the digestion process could be anticipated by using this equilibrium phase 
behaviour as a calibration as previously demonstrated with light sensitive inverse phases.43 However, 
this was not the case due to the nature of the phase transition at play in this system:from lamellar 
vesicles to the HII phase. This is a phase transition that phospholipid bilayers generally try to avoid as 
energetically unfavourable changes must occur for the transformation to proceed, namely, changes in 
curvature, the formation of voids in the hydrophobic core and the exposition of lipid chains to 
interbilayer water.25, 44 The avoidance of the formation of HII phase has also been observed in bicontinuous 
cubic nanostructures.45-46 By preforming the lipid particles at equilibrium, these phenomena are avoided. 
Moreover, the complexity of this biological system – the interfacial nature of the enzyme and the effect 
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of the other product of enzyme action, phosphorylcholine and phosphorylethanolamine, upon the 
colloidal stability of the particle cannot be reproduced at equilibrium. 
The evolution and phase separation of DAG in sPC bilayers did not result in a phase transition to 
inverse phases as demonstrated in equilibrium studies. Instead, DAG escapes from the lipid bilayer, 
which is attributed to a mismatch in molecular shape and hydrophobicity, and a limited capability to 
form hydrogen bonds. It is not possible for the –OH group of the DAG4 molecule to form hydrogen 
bonds with the RN(CH3)3+ moiety of the sPC headgroup as trimethyl ammonium moieties cannot act as 
a hydrogen bond donor group. This absence of hydrogen bonding interaction was confirmed by 
molecular simulations (Fig. SI-9). This molecular behaviour allows for DAG to act as a mobile 
messenger. Moreover, this effect may be exaggerated by the fluidity of the linoleic acid chains of the 
sPC,47-48 as compared to the palmitoyl/oleoyl chains of the ePE. The speed of lipid movement may also 
play a role in the reorganisation of the lipidic bilayer. The spontaneous translocation of phospholipids 
across the bilayer has been estimated to be extremely slow (10-15 s-1),31 a process that is influenced by 
membrane fluidity as well as size of the lipid that is moving.32 The translocation of the smaller, 
hydrophobic DAG molecules occurs much faster (63 s-1),49 where this mismatch in speed may add to 
the propensity for phase separation. Thus, in the case of sPC, it is more favourable fo  the DAG to 
escape from the bilayer as a DAG-rich second phase than to reorganise within the vesicle lipid bilayers. 
In contrast, ePE bilayers incorporated the DAG produced by PLC hydrolysis into the lipid bilayer, 
resulting in the formation of negative curvature. This follows their intrinsic ability to form inverse 
phases. The production of DAG forces the partial dehydration of the headgroups and an increase in the 
hydrophobic volume.47 The DAG1 is able to stay within the ePE bilayer, as the –OH group of the DAG1 
is able to establish hydrogen bonds with the donor RNH3+group on the PE headgroup, as confirmed by 
molecular simulations (Fig. SI-10). The resulting phase transition from Lg to HII results from the 
dynamic equalisation between the free energy of hydrocarbon chain packing and the curvature energy, 
a function of electrostatic interactions and hydration.50-51 In the absence of the surfactant, the vesicles 
are able to fuse as there is no barrier to the formation of a highly curved bridge between the 
multilamellar vesicles.52 
The most significant differences between the behaviour of PCs and PEs relate to the behaviour of 
their headgroups at the interface. Reported and experimental differences betwen the headgroups of PE 
and PC are shown in Table 2 and reported in Figs 2 and 4. PC bilayers have a larger bilayer thickness 
(dHH) as well as separation (dW) than PE bilayers. Interestingly, the presence of the stabiliser in the sPC 
bilayer seems to increase dHH and reduce the dW. This is attributed to a slight reduction of membrane 
fluidity in the presence of a stabiliser, and hence leading to reduction in undulation-caused repulsion 
forces going hand in hand with a reduction in the interlamellar distance, dW. The large headgroup area 
of PCs prevents the formation of inverse phases, whereas the reduced headgroup area of the PE results 
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in smaller dW and decreased mean square membrane fluctuations by factor of 2-4 (referring to the Caillé 
parameter).53-55  
Table 2 – Molecular dimensions from literature comparing features of the PC and PE headgroups.56-57 
 PC PE 
Headgroup diameter (Å) 10 8 
Headgroup size (Å3) 344 246 
Bulk water/lipid molecule 23 12 
 
In the formulation of new drug delivery systems, it is important to keep in mind that static models 
cannot be solely relied upon to predict their fate in vivo. The human body is a complex achine in 
which most biochemical reactions are constantly changing, including the ones involving the digestions 
of drugs and their delivery systems. Consequently, their kinetic states and are not in thermodynamic 
equilibrium. 
Conclusions 
This study gives insights into the manipulation of lipidic membranes in response to exposure to 
phospholipase C. The roles of phosphatidylcholines and phosphatidylethanolamines within a lipid 
bilayer differ greatly. Bilayers formed by the two phospholipids respond to the stress of hydrolysis in 
two different ways. The mismatch of the DAG molecules and sPC causes the escape of the pr duced 
DAG4 due to poor interaction with the remaining sPC molecules in the lipid bilayer; wh reas the 
produced DAG1 molecules contributes to the creation of negative curvature in the ePE bilayer as they 
remained in the bilayer due to hydrogen bonding. This contrasts with what was observed at quilibrium 
and has been observed in the literature, highlighting that dynamic self-assembly of lipids cannot be 
predicted by equilibrium models. As can be seen, the chemistry of the phospholipid head group plays 
an important role in the fate of the DAG. From a biophysics point of view, this study upports the 
consensus that the formation of lipid domains play essential roles in cellular response to stress. The 
DAG produced from a PC rich domain is more likely to escape the lipid bilayer, whereas the DAG 
produced in a PE rich domain is likely to be retained within the lipid bilayer nd so influence lipid 
packing through dehydration and expansion of the lipidic volume. This study links the biochemical 
changes in PE and PC membranes that are required to effect cellular fusion and intracellular signalling; 
phenomena that can be tuned to deliberately trigger phase transitions in lyotropic liquid-crystalline 
materials that mimic physiological responses to disease states. 
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Towards understanding the in vivo fate of lipid-based drug delivery systems, this study looks at the structural 
consequences of PLC catalysed hydrolysis of phospholipid bilayers. Structural transformations of vesicles are 
determined by the movement of hydrophobic products which, in turn, are dependent on the ability of the headgroup 
to form hydrogen bonds. 
